Overview:
For patients with nAMD or DME, intravitreal anti-VEGF injections are the standard of care – but poor adherence and high treatment burden have led to suboptimal visual outcomes in the real world compared with clinical trial results. New anti-VEGF therapies are now available, and so are new technologies that can give eye care providers insights into how patients feel about these diseases and treatments.
In this engaging, interactive, and innovative session, the audience will vote on the issues they think patients and eye care providers are facing in regard to nAMD, DME, and its treatments – and then see the insights that AI has collected online about these questions. A panel of expert faculty will show what these insights mean for your practice!
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Outline disease and treatment-specific concerns among patients with nAMD that impact quality of life
- Summarize disease and treatment-specific concerns among patients with DME that impact quality of life
- Apply real-world evidence and best practices toward the development of treatment plans for the management of nAMD
- Integrate evidence regarding advanced dosing strategies into individualized management plans for patients with DME
Benefits of Attending
- Insights into patient beliefs about nAMD, DME, and their treatment
- Opportunities for patient education
- Big picture on how new anti-VEGFs can fit into patient management
Program Chair - Shaun Ittiara, MD, FACS, FASRS
Vitreoretinal Specialist
President at Retinal Vitreal Consultants
Clinical Associate at The University of Chicago
Chicago, IL
Dimitra Skondra, MD, PhD
Assistant Professor of Ophthalmology and Visual Science
Director, J. Terry Ernest Ocular Imaging Center
Vitreoretinal Service
The University of Chicago
Chicago, IL
Raman Bhakhri, OD, FAAO
Associate Professor of Optometry
Illinois College of Optometry
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is accredited by COPE to provide continued education to optometrists.